RONAPREVE Trademark

Trademark Overview


On Monday, June 29, 2020, a trademark application was filed for RONAPREVE with the United States Patent and Trademark Office. The USPTO has given the RONAPREVE trademark a serial number of 90026296. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, December 6, 2021. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The RONAPREVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
ronapreve

General Information


Serial Number90026296
Word MarkRONAPREVE
Filing DateMonday, June 29, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, December 6, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 8, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, July 24, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, December 6, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, December 6, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 19, 2021ASSIGNED TO EXAMINER
Friday, April 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 14, 2021EXTENSION 1 GRANTED
Wednesday, April 14, 2021EXTENSION 1 FILED
Wednesday, April 14, 2021TEAS EXTENSION RECEIVED
Tuesday, November 3, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 8, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 8, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 19, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, July 31, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 31, 2020EXAMINER'S AMENDMENT ENTERED
Friday, July 31, 2020NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINERS AMENDMENT E-MAILED
Friday, July 31, 2020EXAMINERS AMENDMENT -WRITTEN
Friday, July 24, 2020ASSIGNED TO EXAMINER
Friday, July 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, July 23, 2020PETITION TO DIRECTOR - GRANTED
Tuesday, July 21, 2020ASSIGNED TO PETITION STAFF
Monday, July 13, 2020TEAS PETITION TO DIRECTOR RECEIVED
Thursday, July 9, 2020TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Thursday, July 9, 2020TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, July 2, 2020NEW APPLICATION ENTERED IN TRAM